EpLink and Aurora Cannabis to partner on study for adults with drug-resistant epilepsy
First adult study in Canada to examine the impact of cannabis oil on the reduction of convulsive seizures Toronto, ON – February 20, 2019 – EpLink – The Epilepsy Research Program of the Ontario Brain Institute – in collaboration with Aurora Cannabis’ wholly owned subsidiary MedReleaf – today announced the initiation of a clinical study…